Skip to main content
21+Industry intelligence — not direct nicotine sales
Science & Policy

New study examines GLP-1 impact on interactions with criminal justice system, employment, housing stability

Summary: A wave of clinical trials have begun to test the ability of GLP-1 weight loss drugs to quell various substance use disorders, with some promising results.

A wave of clinical trials have begun to test the ability of GLP-1 weight loss drugs to quell various substance use disorders, with some promising results. A new trial announced…

Adults 21+. WINDBAR does not sell nicotine products on this site. Compliance statement.

← Back to Science & Policy